Related Experiment Video

Updated: Aug 6, 2026

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
05:56

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

[Interferon system in children with cystic fibrosis]

N R Badriashvili, N L Topuridze, G S Chakhunashvili

    Georgian Medical News
    |August 15, 2006
    PubMed

    Insights

    Patients with cystic fibrosis exhibit significantly lower interferon levels, suggesting interferon therapy could be beneficial, especially for respiratory infections.

    Area of Science:

    • Immunology
    • Pediatrics
    • Pulmonology

    Context:

    • Cystic fibrosis (CF) is a genetic disorder affecting multiple organs, particularly the lungs.
    • Leukocyte function, specifically interferon production, is crucial for immune response.
    • Pediatric patients with CF often experience recurrent respiratory infections.

    Purpose:

    • To investigate interferon-producing leukocyte function in children with cystic fibrosis.
    • To compare interferon levels in CF patients with healthy children.
    • To evaluate the potential of interferon therapy in managing CF complications.

    Summary:

    • This study analyzed interferon production in 32 pediatric patients with cystic fibrosis (CF) and 30 healthy children.
    • Interferon levels in CF patients ranged from 0-2 U/ml, significantly lower than the normal range of 4-24 U/ml.
    • Both mixed and bronchopulmonary forms of CF were assessed, with severity categorized by the Shvaxman scale.

    Impact:

    • Findings indicate impaired interferon production in children with cystic fibrosis.
    • Results support the recommendation of interferon therapy as an adjunct treatment for CF, particularly during acute respiratory viral infections and outbreaks.
    • Early intervention with interferon may improve outcomes in hospitalized CF patients when outpatient treatments fail.

    More Related Videos

    Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons09:11

    Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons

    Published on: August 23, 2016

    Related Concept Videos

    Cystic Fibrosis: Management01:24

    Cystic Fibrosis: Management

    Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
    Sinus disease and chronic sinusitis...
    Inhibitors of Viral Protein Synthesis01:30

    Inhibitors of Viral Protein Synthesis

    Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
    Cystic Fibrosis: Pathogenesis01:23

    Cystic Fibrosis: Pathogenesis

    Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
    CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
    Respiratory Syncytial Virus Disease01:29

    Respiratory Syncytial Virus Disease

    Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
    Immunodeficiency Diseases01:25

    Immunodeficiency Diseases

    Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
    There are three main causes of immunodeficiency disorders...
    Immune Response Against Viral Pathogens01:29

    Immune Response Against Viral Pathogens

    The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
    NK Cells
    NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...